Quick Answer
Arcadia Biosciences, Inc. reported Stockholders Equity of $4.14 million for fiscal year 2025.
Arcadia Biosciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.14M | -33.5% |
| 2024 | $6.22M | -51.5% |
| 2023 | $12.84M | -38.9% |
| 2022 | $21.03M | -32.4% |
| 2021 | $31.09M | +12.1% |
| 2020 | $27.73M | +259.8% |
| 2019 | $7.71M | -39.9% |
| 2018 | $12.81M | +60.0% |
| 2017 | $8.01M | -63.9% |
| 2016 | $22.20M | -44.8% |
| 2015 | $40.23M | +147.5% |
| 2014 | -$84.77M | -390.1% |
| 2013 | -$17.30M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.44M | -47.1% | +20.1% |
| June 30, 2025 | $4.53M | -61.3% | -49.1% |
| March 31, 2025 | $8.90M | -16.2% | +43.1% |
| December 31, 2024 | $6.22M | -51.5% | -39.5% |
| September 30, 2024 | $10.29M | -33.8% | -12.1% |
| June 30, 2024 | $11.70M | -34.5% | +10.2% |
| March 31, 2024 | $10.62M | -36.9% | -17.3% |
| December 31, 2023 | $12.84M | -38.9% | -17.3% |
- Arcadia Biosciences, Inc. showed a decrease of -33.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, Arcadia Biosciences, Inc.’s stockholders equity has grown by 123.9% (from -$17.30 million to $4.14 million).
- The most recent figure is from Arcadia Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: